Aptus Endosystems
Welcome

An estimated 1.5 million Americans have an abdominal aortic aneurysm (AAA) which can be life-threatening if left untreated. Endovascular aneurysm repair (EVAR) has become the standard of care despite shortcomings in long term results. We are focused on developing innovative technologies to transform EVAR and provide physicians and patients with a definitive solution for AAA treatment.

Latest News

December 12, 2011
Aptus Endosystems Completes First HeliFX™ Procedures in US

November 21, 2011
Aptus Receives FDA Clearance for HeliFX™ System

October 31, 2011
Aptus Endosystems Announces New Product Names